-
Edoxaban, sold
under the
brand name
Lixiana among others, is an
anticoagulant medication and a
direct factor Xa inhibitor. It is
taken by mouth. Compared...
-
comorbidities Treatment Anticoagulants:
edoxaban, tinzaparin,
unfractionated heparin Medication apixaban,
edoxaban, and
rivaroxaban Deaths 100,000–300,000...
- clotting) drugs,
including factor Xa
inhibitors (rivaroxaban,
apixaban and
edoxaban), dabigatran, and
heparins (including fondaparinux, low
molecular weight...
- (dabigatran) and
factor Xa
inhibitor (rivaroxaban, apixaban,
betrixaban and
edoxaban), and they have been
shown to be as good or
possibly better than the coumarins...
-
approved in
Europe in 2011 and in the
United States in 2012. The
third one
edoxaban (Lixiana, Savaysa) was
approved in ****an in 2011 and in
Europe and the...
-
dabigatran and
edoxaban do. A
Cochrane review found that
there is no
evidence of a
difference between oral DTIs (dabigatran, rivaroxaban,
edoxaban, apixaban)...
-
direct oral
anticoagulant drugs (DOACs, e.g. dabigatran, rivaroxaban,
edoxaban, or apixaban) is recommended. If the
patient is 'low risk'
using the CHA2DS2-VASc...
-
directly acting oral anticoagulants: dabigatran, rivaroxaban, apixaban, and
edoxaban).
Theories on the
coagulation of
blood have
existed since antiquity. Physiologist...
-
Rivaroxaban competes with
other newer generation anticoagulants such as
edoxaban, apixaban, and
dabigatran as well as with the
generic anticoagulant warfarin...
-
symptomatic heart failure.
Apixaban and
other anticoagulants (dabigatran,
edoxaban and rivaroxaban)
appear equally effective as
warfarin in
preventing non-hemorrhagic...
